Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate MAIA Biotechnology, Inc. before investing.

In this article, we go over a few key elements for understanding MAIA Biotechnology, Inc.’s stock price such as:

• MAIA Biotechnology, Inc.’s current stock price and volume
• Why MAIA Biotechnology, Inc.’s stock price changed recently
• Upgrades and downgrades for MAIA from analysts
• MAIA’s stock price momentum as measured by its relative strength

About MAIA Biotechnology, Inc. (MAIA)

Before we jump into MAIA Biotechnology, Inc.’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

MAIA Biotechnology, Inc., together with its subsidiaries, immuno-oncology company, focuses on the development and commercialization of drugs with novel mechanisms of action that are intended to improve and extend the lives of people with cancer. Its lead program is THIO, a potential cancer telomere targeting agent in clinical development for the treatment of NSCLC patients with telomerase-positive cancer cells. The company was incorporated in 2018 and is headquartered in Chicago, Illinois.

Want to learn more about MAIA Biotechnology, Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about MAIA Biotechnology, Inc..

MAIA Biotechnology, Inc.’s Stock Price as of Market Close

As of December 03, 2025, 4:00 PM, CST, MAIA Biotechnology, Inc.’s stock price was $1.120.

MAIA Biotechnology, Inc. is down 5.08% from its previous closing price of $1.180.

During the last market session, MAIA Biotechnology, Inc.’s stock traded between $1.080 and $1.200. Currently, there are approximately 33.20 million shares outstanding for MAIA Biotechnology, Inc..

MAIA Biotechnology, Inc.’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

MAIA Biotechnology, Inc. Stock Price History

MAIA Biotechnology, Inc.’s (MAIA) price is currently down 5.08% so far this month.

During the month of December, MAIA Biotechnology, Inc.’s stock price has reached a high of $1.460 and a low of $1.070.

Over the last year, MAIA Biotechnology, Inc. has hit prices as high as $2.740 and as low as $0.870. Year to date, MAIA Biotechnology, Inc.’s stock is down 43.43%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused MAIA Biotechnology, Inc. Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of December 02, 2025, there were 0 analysts who downgraded MAIA Biotechnology, Inc.’s stock and 1 analyst who upgraded over the last month.

Additionally, you'll want to evaluate MAIA Biotechnology, Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on MAIA Biotechnology, Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about MAIA Biotechnology, Inc. (MAIA) by visiting AAII Stock Evaluator.

Relative Price Strength of MAIA Biotechnology, Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of December 02, 2025, MAIA Biotechnology, Inc. has a weighted four-quarter relative price strength of -17.70%, which translates to a Momentum Score of 12 and is considered to be Very Weak.

Want to learn more about how MAIA Biotechnology, Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

MAIA Biotechnology, Inc. Stock Price: Bottom Line

As of December 3, 2025, MAIA Biotechnology, Inc.’s stock price is $1.120, which is down 5.08% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like MAIA Biotechnology, Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.